Clinical Trial

Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
In this study, the investigators want to find out whether a new wearable sensor system, called the M2VS system, can reliably measure heart activity, blood pressure, and other vital signs over 24 hours during normal daily life. The investigators also want to compare the M2VS system with the standard devices currently used for long-term heart and blood pressure monitoring, such as a Holter ECG and an ambulatory blood pressure monitor (ABPM). This will provide an estimation of the accuracy of the M2VS system's ECG and blood pressure measurements compared to the standard devices. The aim of the study is to assess how reliable the M2VS system is in terms of data completeness and how comfortable it is to wear compared with the usual monitoring devices. In the future, the results of this study may help make the monitoring of heart and blood vessel diseases more comfortable and easier for patients.
Trial Details
NCT Number NCT07694570
Lead Sponsor University Hospital, Basel, Switzerland
Collaborators: evismo AG, Bern University of Applied Sciences
Conditions Atrial Fibrillation (Paroxysmal), Hypertension
Enrollment 20 participants
Start Date 2026-07-01
Primary Completion 2026-08 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-10